Sequence 1 (REL , NFKB1 , NFKB2 ( Homo sapiens ))

Sequence REL , NFKB1 , NFKB2 ( Homo sapiens )
Target	REL , NFKB1 , NFKB2 ( Homo sapiens )
Description	ENSG00000162924 2:60881521-60931610:1 V-rel avian reticuloendotheliosis viral oncogene homolog ; ENSG00000109320 4:102501329-102617302:1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 ; ENSG00000077150 10:102394110-102402529:1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
Design	peptides
Chemistry	amino acids
Sequence	LLCDKVQKDDIEVRF
Application	multitargeting
Name	REL , NFKB1 , NFKB2 ( Homo sapiens )

References

Identification of sequences common to more than one therapeutic target to treat complex diseases: simulating the high variance in sequence interactivity evolved to modulate robust phenotypes. Varela MA. BMC Genomics. 2015 Jul 18;16(1):530.

Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience. Hache M, Swoboda KJ, Sethna N, Farrow-Gillespie A, Khandji A, Xia S, Bishop KM. J Child Neurol. 2016 Jun;31(7):899-906. PubMed:26823478

Comments

Not experimentally validated

Background